 |  |
| ABX | ||
| 1,034.483 | ||
| 8.5160 | 0.0083% | |
| BISNIS-27 | ||
| 576.862 | ||
| -3.2970 | -0.0057% | |
| COMPOSITE | ||
| 7,155.294 | ||
| -20.7470 | -0.0029% | |
| DBX | ||
| 1,625.825 | ||
| -10.5660 | -0.0065% | |
| ESGQKEHATI | ||
| 137.127 | ||
| -0.8340 | -0.0060% | |
| ESGSKEHATI | ||
| 135.241 | ||
| -0.8450 | -0.0062% | |
| I-GRADE | ||
| 232.844 | ||
| -2.6390 | -0.0112% | |
| AUDRP | ||
| 10,310.300 | ||
| -10.9000 | -0.1056% | |
| EURRP | ||
| 17,080.200 | ||
| -22.4000 | -0.1310% | |
| JPYRP | ||
| 104.190 | ||
| -0.0400 | -0.0384% | |
| RP | ||
| 15,771.000 | ||
| -13.0000 | -0.0824% | |
| SINRP | ||
| 11,733.600 | ||
| 11.4000 | 0.0973% | |
Sejumlah lembaga asal Indonesia bekerja sama dengan perusahaan farmasi luar negeri dalam mengembangkan produksi vaksin COVID-19 di dalam negeri. Badan Pengawas Obat dan Makanan (BPOM) mencatat setidaknya terdapat lima pengembangan kandidat vaksin COVID-19 yang cukup menjanjikan.
